Home   Contact Us   Sitemap

 Financial & IR Update  News Update  Annual Report 2013-14
Conference Call Invitation - Q4 FY15
Indoco Remedies Q3 Profit After Tax (PAT) grows by 53% - Q3 FY15
Unaudited Standalone Financial Results for the Quarter and Nine Months ended 31st December, 2014 - Q3 FY15
Management Discussion & Analysis - Q3 FY15
Indoco Remedies to buy Piramal's clinical research business, The Economic Times - April 01, 2015
Indoco acquires Piramal's Clinical Research Division - April 01, 2015
Fine Chemicals - Stringent regulations prompt return of manufacturing to the West, IHS Chemical Week - January 26, 2015
more »